Biortica moves closer to ASX listing as Bod shareholders set to vote on deal by Steve Jones May 2, 2024May 2, 2024 Bod Science shareholders will vote on a proposed deal with Biortica Agrimed in the next few […]
Green Farmers parent set to list on ASX as deal with Bod moves closer by Steve Jones March 21, 2024March 21, 2024
Bod strikes deal to keep trading as creditor claims rise beyond A$6m by Steve Jones December 13, 2023December 13, 2023
Bod Science battles for its future as board calls in administrators by Steve Jones November 30, 2023November 30, 2023
Bod announces A$2m capital raise as senior team takes pay cut by Martin Lane November 8, 2023April 30, 2024
Bod eyes opportunities beyond cannabis as Aqua Phase tech passes second bioavailability test by Martin Lane September 27, 2023April 30, 2024
Long-time cannabis critic says medicine’s growth ‘more concerning’ than opioid epidemic by Martin Lane September 18, 2023September 20, 2023
Cannabis executive salaries: who earned what in FY23 by Steve Jones September 13, 2023September 14, 2023
Bod Science clinical trial ‘proves the efficacy of CBD’ for pharmacy sales by Steve Jones September 6, 2023September 7, 2023
